VRAX Earnings
Virax Biolabs Group Limited
1W: -8.3%
1M: -13.7%
3M: -29.3%
YTD: +472.9%
1Y: +255.2%
3Y: -29.0%
$2.20
-0.04 (-1.79%)
Weekly Expected Move ±9.1%
$2
$2
$2
$2
$3
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Last Earnings
2025-12-02
EPS
$-0.49
▼ Miss +0.0%
Revenue
$2K
▲ Beat +0.0%
Next Earnings
2026-12-02
EPS Estimate
$-1.75
Revenue Estimate
$12K
Estimate vs Actual
Earnings Surprise History
0/4
EPS Beats
0/4
Revenue Beats
0%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-08-07 | quarter | 2026-09-30 | $-1.75 | $-1.75 | — | $12,094 | $13,893 |
| 2026-08-07 | quarter | 2026-03-31 | $-1.75 | $-1.75 | — | $10,815 | $12,423 |
| 2026-07-09 | quarter | 2026-09-30 | $-1.75 | $-1.75 | — | $1,222 | $12,094 |
| 2026-07-09 | quarter | 2026-03-31 | $— | $-1.75 | ▼ 1.75 | $— | $10,815 |
| 2026-07-09 | quarter | 2025-03-31 | $— | $-0.34 | ▼ 0.34 | $— | $10,000,000 |
| 2026-07-03 | quarter | 2026-09-30 | $— | $-1.75 | ▼ 1.75 | $— | $1,222 |
| 2026-06-29 | annual | 2027-03-31 | $-0.24 | $-6.00 | ▼ 5.76 | $4,000 | $4,000 |
| 2026-06-29 | annual | 2026-03-31 | $-0.40 | $-10.00 | ▼ 9.60 | $40,000 | $40,000 |
| 2026-06-29 | annual | 2025-03-31 | $-1.48 | $-37.00 | ▼ 35.52 | $25,000 | $25,000 |
| 2026-06-29 | annual | 2023-03-31 | $— | $-3.70 | ▼ 3.70 | $— | $200,000 |
| 2026-06-29 | quarter | 2026-03-30 | $-0.07 | $-1.75 | ▼ 1.68 | $1,401 | $1,401 |
| 2026-04-20 | quarter | 2025-09-30 | $-0.34 | $-0.10 | ▲ 0.24 | $10,000,000 | $10,000,000 |
| 2026-04-20 | quarter | 2025-03-30 | $-0.33 | $-0.34 | ▼ 0.01 | $10,000 | $10,000,000 |
| 2026-04-06 | quarter | 2026-06-30 | $— | $-0.07 | ▼ 0.07 | $— | $1,309 |
| 2026-01-15 | quarter | 2026-03-30 | $— | $-0.07 | ▼ 0.07 | $— | $1,401 |
Earnings Call Transcripts
No transcripts available.